James Quigley
Stock Analyst at Goldman Sachs
(0.22)
# 4,318
Out of 4,495 analysts
329
Total ratings
40.8%
Success rate
-6.9%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €55.00 → €62.50 | $50.70 | +23.27% | 60 | Jul 6, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €89.00 → €84.00 | $76.48 | +9.83% | 10 | Jul 6, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 346.00 → CHF 348.00 | $335.50 | +3.73% | 26 | Jun 30, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 106.00 → CHF 111.00 | $124.30 | -10.70% | 26 | Jun 30, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €230.00 → €229.00 | $233.30 | -1.84% | 30 | Jun 23, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 263.00 → kr 305.00 | $320.55 | -4.85% | 35 | Jun 4, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $41 → $47 | $48.88 | -3.85% | 9 | Jun 3, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | $179.60 | +19.15% | 23 | Apr 23, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | $139.60 | +5.30% | 43 | Apr 16, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 650.00 → CHF 670.00 | $582.60 | +15.00% | 21 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $52.02 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $154.62 | -23.68% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $863.00 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $43.90 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | $13,354.00 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | $1.25 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | $4.99 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | $74.10 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | $47.05 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | $26.64 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.84 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | $807.50 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | $1,923.50 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $30.59 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $29.78 | n/a | 1 | Jun 20, 2018 |
Bayer Aktiengesellschaft
Jul 6, 2026
Maintained: Buy
Price Target: €55.00 → €62.50
Current: $50.70
Upside: +23.27%
Sanofi
Jul 6, 2026
Maintained: Hold
Price Target: €89.00 → €84.00
Current: $76.48
Upside: +9.83%
Roche Holding AG
Jun 30, 2026
Maintained: Hold
Price Target: CHF 346.00 → CHF 348.00
Current: $335.50
Upside: +3.73%
Novartis AG
Jun 30, 2026
Maintained: Sell
Price Target: CHF 106.00 → CHF 111.00
Current: $124.30
Upside: -10.70%
Sartorius Aktiengesellschaft
Jun 23, 2026
Maintained: Hold
Price Target: €230.00 → €229.00
Current: $233.30
Upside: -1.84%
Novo Nordisk A/S
Jun 4, 2026
Maintained: Hold
Price Target: kr 263.00 → kr 305.00
Current: $320.55
Upside: -4.85%
Novo Nordisk
Jun 3, 2026
Maintained: Hold
Price Target: $41 → $47
Current: $48.88
Upside: -3.85%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: $179.60
Upside: +19.15%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: $139.60
Upside: +5.30%
Lonza Group AG
Jan 29, 2026
Maintained: Buy
Price Target: CHF 650.00 → CHF 670.00
Current: $582.60
Upside: +15.00%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $52.02
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $154.62
Upside: -23.68%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $863.00
Upside: -
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $43.90
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: $13,354.00
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: $1.25
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: $4.99
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: $74.10
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: $47.05
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: $26.64
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $2.84
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: $807.50
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: $1,923.50
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $30.59
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $29.78
Upside: n/a